JAADi-Supplementary Materials-Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://data.mendeley.com/datasets/ftrzwhz67t
下载链接
链接失效反馈官方服务：
资源简介：
JAAD International
Supplementary Materials
Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis
创建时间：
2025-11-20
